Myelodyplastic Syndrome

In the UK Markey Cancer Center, the Hematology and Blood & Marrow Transplantation Program provides patients care customized to fit their needs.

Our team approach

The Hematology and Blood & Marrow Transplant team treats all cancers related to the blood and lymphatic system, as well as other blood-related diseases, including myelodysplastic syndrome and other conditions that stem from a bone marrow failure. Our team works together providing each member’s individual expertise to offer patients personalized treatment plans suited for their needs.

Myelodyplastic syndrome (MDS) can occur on its own or secondary to other conditions. The treatment is individualized depending on its severity. In early stage MDS, only supportive treatment is given. In later stages, demethylating agents or even a stem cell or bone marrow transplant may be necessary.

Markey has provided state-of-the-art cancer care for more than 20 years, and we are proud to be the only cancer center in Kentucky designated by the National Cancer Institute. In August 2017, Markey was designated as one of the Top 50 Cancer Centers in the nation by U.S. News & World Report. In 2020, Markey rose to the No. 29 ranked cancer center in the nation.

For more information on the treatment of myelodysplastic syndrome, please visit our chemotherapy webpage.

Clinical trials

Clinical trials help keep our cancer care on the leading edge by allowing researchers to apply cancer knowledge as it develops to give you the best chance of survival.

At Markey, our specialists place a high value on all areas of myelodysplastic syndrome treatment, from patient care designed for the unique patient to developing treatments of the future.

Download the Markey Cancer Center Clinical Trials app.

Request an appointment online or call 859-257-4488 or 866-340-4488 (toll free).